Publications 2025

  1. Ronga MG, Gesualdi F, Bonfrate A, Patriarca A, Ferrand R, Crehange G,  Buvat I, De Marzi L. Comparison of secondary radiation dose contribution between pencil beam scanning and scattered delivery for proton and VHEE radiotherapy, Med Phys, in press, 2025. DOI: https://aapm.onlinelibrary.wiley.com/doi/10.1002/mp.17700 

  2. Malhaire C, Umay O, Cockenpot V, Selhane F, Ramtohul T, Reyal F, Pierga JY, Romano E, Vincent-Salomon A, Kirova Y, Laas E, Brisse HJ, Frouin F. Predicting axillary residual disease after neoadjuvant therapy in breast cancer using baseline MRI and ultrasound. Eur Radiol. 2025 Feb 8. DOI: 10.1007/s00330-025-11408-4

  3. Seban RD, Buvat I, Champion L, Bidard FC, Kieffer Y, Vincent-Salomon A, Peltier A, Mechta-Grigoriou F. Beyond FAP: ANTXR1 as a Novel Target for PET Imaging and Radio-Ligand Therapy in Immuno-Oncology? (Letter to the editor). Eur J Nucl Med Mol Imaging, in press, 2025. https://link.springer.com/article/10.1007/s00259-025-07126-0 

  4. Lehrer EJ,  Khunsriraksakul C, Garrett S, Trifiletti DM, Sheehan JP, Guckenberger M, Louie AV, Siva S, Ost P, Goodman KA, Dawson LA, Tchelebi LT, Yang JT, Showalter TN, Park HS, Spratt DE, Kishan AU, Gupta GP, Shah C, Fanti S, Calais J, Wang M, Schmitz K, Liu D, Abraham JA, Dess RT, Buvat I, Solomon B, Zaorsky NG. Future directions in the evaluation and management of newly diagnosed metastatic cancer. Crit Rev Oncol Hematol, 104631, 2025. DOI: https://doi.org/10.1016/j.critrevonc.2025.104631 

  5. Lekadir K, Frangi AF, Porras AR, Glocker B, Cintas C, Langlotz CP, Weicken E, Asselbergs FW, Prior F, Collins GS, Kaissis G, Tsakou G, Buvat I, Kalpathy-Cramer J, Mongan J, Schnabel JA, Kushibar K, Riklund K, Marias K, Amugongo LM, Fromont LA, Maier-Hein L, Alberich LC, Martí-Bonmatí L, Cardoso MJ, Bobowicz M, Shabani M, Tsiknakis M, Zuluaga MA, Fritzsche MC, Camacho M, Linguraru MG, Wenzel M, De Bruijne M, Tolsgaard MG, Goisauf M, Abadía MC, Papanikolaou N, Lazrak N, Pujol O, Osuala R, Napel S, Joshi S, Klein S, Aussó S, Rogers WA, Puig-Bosch X, Salahuddin Z, Starmans MPA, and the FUTURE-AI Consortium. FUTURE-AI: International consensus guideline for trustworthy and deployable artificial intelligence in healthcare. BMJ British Medical Journal, 388, 2025. DOI: https://doi.org/10.1136/bmj-2024-081554.

  6. Captier N, Lerousseau M, Orlhac F, Hovhannisyan-Baghdasarian N, Luporsi M, Woff E, Lagha S, Salamoun Feghali P, Lonjou C, Beaulaton C, Salmon H, Walter T, Buvat I, Girard N, Barillot E. Integration of clinical, pathological, radiological, and transcriptomic data improves the prediction of first-line immunotherapy outcome in metastatic non-small cell lung cancer. Nature Comm, 16:614, 2025. DOI: https://doi.org/10.1038/s41467-025-55847-5 

  7. Seban RD, Champion L, De Moura A, Lerebours F, Loirat D, Pierga JY, Djerroudi L, Genevee T, Huchet V, Jehanno N, Bidard FC, Buvat I. Pre-treatment [18F]FDG PET/CT biomarkers for the prediction of antibody-drug conjugates efficacy in metastatic breast cancer, Eur J Nucl Med Mol Imaging, 52(2):708-718, 2025. DOI: https://doi.org/0.1007/s00259-024-06929-x

  8. Sitarz M, Ronga MG, Gesualdi F, Bonfrate A, Wahl N, De Marzi L. Implementation and validation of a very-high-energy electron model in the matRad treatment planning system. Med Phys, 52(1):518-529, 2025. DOI: 10.1002/mp.17392.

  9. Legdeur N, Badissi M, Venkatraghavan V, Woodworth DC, Orlhac F, Vidal JS, Barkhof F, Kawas CH, Visser PJ, Corrada MM, Muller M, Rhodius-Meester HFM. The temporal relation of physical function with cognition and the influence of brain health in the oldest-old: The UCI 90+ Study and EMIF-AD 90+ Study. Gerontology, 71(1):13-27, 2025. DOI: 10.1159/000542395